- Home
- AIG vs MDLN Comparison
AIG vs MDLN Comparison
Compare AIG & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIG | MDLN |
|---|---|---|
| Founded | 1919 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9B | 37.4B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIG | MDLN |
|---|---|---|
| Price | $78.65 | $39.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 23 |
| Target Price | ★ $86.46 | $50.48 |
| AVG Volume (30 Days) | 3.1M | ★ 5.3M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | ★ 350.23 | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | ★ $26,775,000,000.00 | N/A |
| Revenue This Year | $11.55 | $10.88 |
| Revenue Next Year | $5.26 | $7.69 |
| P/E Ratio | ★ $55.94 | $658.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $71.25 | $32.82 |
| 52 Week High | $87.35 | $50.88 |
Technical Indicators
Market Signals| Indicator | AIG | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 47.10 |
| Support Level | $75.48 | $38.08 |
| Resistance Level | $79.00 | $43.87 |
| Average True Range (ATR) | 1.51 | 1.56 |
| MACD | -0.12 | -0.14 |
| Stochastic Oscillator | 50.57 | 40.47 |
Price Performance
Historical ComparisonAbout AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.
About MDLN Medline Inc. Class A Common Stock
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.